Organization
Yinfeng Gene Technology Co Ltd, Jinan, China
4 abstracts
Abstract
PD-L1 expression in Chinese patients with solid tumor and its correlation with gene alternations.Org: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Department of Oncology, Shijiazhuang People’s Hospital, Shijiazhuang, China, Department of Gynecology, The 980th Hospital of the PLA Joint Logistic Support Force, Shijiazhuang, China, Yinfeng Gene Technology Co Ltd, Jinan, China, Clinical Oncology Research Alliance, Tianjin, China,
Abstract
The landscape of BRCA1 and BRCA2 alterations in Chinese ovarian cancer patients.Org: Department of Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China, Department of Gynecology, The 980th Hospital of the PLA Joint Logistic Support Force, Shijiazhuang, China, Yinfeng Gene Technology Co Ltd, Jinan, China, Clinical Oncology Research Alliance, Tianjin, China,
Abstract
Comprehensive genomic landscape in pancreatic cancer using whole-exome sequencing.Org: Department of Hepatobiliary, The Second Affiliated Hospital of Army Medical University, Chongqing, China, Yinfeng Gene Technology Co Ltd, Jinan, China, Clinical Oncology Research Alliance, Tianjin, China,
Abstract
Genomic characterization of papillary thyroid carcinoma in Chinese Shandong population.Org: Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Jinan, China, Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, Department of Thyroid and Breast, The 960th hospital of PLA, Jinan, China, Department of External Medicine, Jinan Huaiyin People's Hospital, Jinan, China, Second Department of Breast Diseases/Second Department of Thyroid Diseases, The Second People's Hospital of Shandong Province, Jinan, China,